Season three of “Twenty-Four Seven: A Podcast About Caregiving” is now available
October 27, 2022
In this new season, host Kitty Eisele will explore the importance of how caregivers for loved ones with dementia are portrayed in popular culture.
Study links omega-3s to improved brain structure, cognition at midlife
October 5, 2022
Holy mackerel! Could eating salmon, cod, tuna, herring or sardines keep our brains healthy and our thinking agile in middle age? New research makes this connection. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Oct. 5, 2022) — Eating cold-water fish and other sources of omega-3 fatty acids may preserve brain health and enhance cognition in […]
Global study, supported by Alzheimer’s Association, aims to shed light on COVID-19’s impact on the brain
September 22, 2022
Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Sept. 22, 2022) — Debra Gutierrez of Von Ormy, Texas, near San Antonio has been an active person all her life. An ophthalmology technician at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), she works in a clinic that sees scores […]
Novel brain injury treatment tested in 1st human subject
June 17, 2022
An experimental brain injury medication conceived in laboratories at UT Health San Antonio was tested Tuesday, June 14, in the first human subject. If the drug, called AST-004, performs well in human studies, it will be an urgently needed and novel treatment for stroke and traumatic brain injury victims, including those with concussions.
Novel brain injury treatment tested in 1st human subject
June 15, 2022
Drug conceived at UT Health San Antonio was safe, effective in animal studies Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO, TEXAS, AND GROTON, CONN. (Wednesday, June 15, 2022) — An experimental brain injury medication conceived in laboratories at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was tested Tuesday, […]
In the race to solve Alzheimer’s disease, scientists find more needles in the haystack
April 20, 2022
Thanks to international collaboration, more genetic variations for Alzheimer’s disease are known today than ever before. The list of gene variants recognized for late-onset Alzheimer’s grew from one in 2009 to 40 in 2022. This month, scientists published a list of 75, some of which are considered as prime drug targets. Drug development is underway.
